Literature DB >> 16336486

The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW.

Andreas M Pleil1, Karen S Coyne, Pat Ray Reese, Zhanna Jumadilova, Eric S Rovner, Con J Kelleher.   

Abstract

OBJECTIVE: This study evaluated the validity of three single-item, patient-rated, interviewer-administered, global assessments of treatment benefit, satisfaction with treatment and willingness to continue treatment, collectively referred to as the BSW.
METHODS: The BSW, micturition diaries, the Overactive Bladder Questionnaire (OAB-q) and the King's Health Questionnaire (KHQ) were included in part or in total in three OAB clinical trials. Discriminant validity for full and dichotomized responses was assessed with anovas models and correlations were used to evaluate construct validity.
RESULTS: The BSW demonstrated significant differences among the majority of the response levels on all measures of micturitions in all studies. The BSW also demonstrated discriminant validity with the OAB-q and the KHQ. BSW measures demonstrated significant differences among the change scores for all subscales of the OAB-q and the majority of the KHQ domains with both full and dichotomized responses. Patients who were dissatisfied with treatment and those unwilling to continue treatment also reported significantly worse OAB-q and KHQ scores compared with those who were satisfied with treatment or willing to continue treatment. BSW measures were moderately correlated with the micturition variables, moderate to strongly correlated with the OAB-q and weak to moderately with the KHQ, providing support for the construct validity of the BSW measures.
CONCLUSIONS: The BSW is a useful tool to capture patients' global impressions of three key elements of treatment outcome: a perceived benefit, satisfaction with treatment, and the willingness to continue treatment, and can facilitate patient-physician communication as well as be informative to researchers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336486     DOI: 10.1111/j.1524-4733.2005.00069.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  25 in total

1.  Low persistence of anticholinergic drug use in Sweden.

Authors:  Love Linnér; Helena Schiöler; Eva Samuelsson; Ian Milsom; Fredrik Nilsson
Journal:  Eur J Clin Pharmacol       Date:  2011-05       Impact factor: 2.953

2.  Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.

Authors:  Ha Na Lee; Young-Suk Lee; Ji-Yeon Han; Jae Yong Jeong; Myung-Soo Choo; Kyu-Sung Lee
Journal:  Int Urogynecol J       Date:  2010-07-20       Impact factor: 2.894

3.  The minimum important difference for the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire.

Authors:  M M Mamik; R G Rogers; C R Qualls; J D Morrow
Journal:  Int Urogynecol J       Date:  2014-02-22       Impact factor: 2.894

4.  Randomised clinical trial investigating self-assembling peptide P11-4 in the treatment of early caries.

Authors:  F Bröseler; C Tietmann; C Bommer; T Drechsel; M Heinzel-Gutenbrunner; S Jepsen
Journal:  Clin Oral Investig       Date:  2019-04-29       Impact factor: 3.573

5.  Defining efficacy in the treatment of overactive bladder syndrome.

Authors:  Sagar Shah; Victor W Nitti
Journal:  Rev Urol       Date:  2009

Review 6.  Voice-Related Patient-Reported Outcome Measures: A Systematic Review of Instrument Development and Validation.

Authors:  David O Francis; James J Daniero; Kristen L Hovis; Nila Sathe; Barbara Jacobson; David F Penson; Irene D Feurer; Melissa L McPheeters
Journal:  J Speech Lang Hear Res       Date:  2017-01-01       Impact factor: 2.297

7.  [Development and validation of a generic questionnaire for evaluating satisfaction in patients with chronic disease: the SAT-Q Questionnaire].

Authors:  Pablo Rebollo; Jesús Cuervo; Guillermo Villa; Maria Jesús Barreda; Salvador Tranche; Maria Amor Sánchez-Baragaño; Miguel Ángel Prieto
Journal:  Aten Primaria       Date:  2010-03-20       Impact factor: 1.137

8.  Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study.

Authors:  Hahn-Ey Lee; Sung Yong Cho; Sangim Lee; Myong Kim; Seung-June Oh
Journal:  Int Neurourol J       Date:  2013-03-31       Impact factor: 2.835

9.  Efficacy and tolerability of combined medication of two different antimuscarinics for treatment of adults with idiopathic overactive bladder in whom a single agent antimuscarinic therapy failed.

Authors:  Junseok Yi; Seong Jin Jeong; Min Soo Chung; Hongzoo Park; Sang Wook Lee; Seung Hwan Doo; Cheol Yong Yoon; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

10.  Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation.

Authors:  Linda Cardozo; Timothy Hall; John Ryan; Caty Ebel Bitoun; Imran Kausar; Amanda Darekar; Adrian Wagg
Journal:  Int Urogynecol J       Date:  2012-05-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.